Clark L J, Edington K, Swan I R, McLay K A, Newlands W J, Wills L C, Young H A, Johnston P W, Mitchell R, Robertson G
Beatson Institute for Cancer Research, CRC Beatson Laboratories, Glasgow, U.K.
Br J Cancer. 1993 Sep;68(3):617-20. doi: 10.1038/bjc.1993.396.
We have examined the incidence of Harvey ras mutations in human squamous cell carcinomas (SCC) of the upper aerodigestive tract using the polymerase chain reaction (PCR) followed by direct sequencing. No mutations were detected at codons 12, 13, 59 or 61 of this gene in any of six papillomas, five erythroplakias, 56 squamous cell carcinomas, and 16 SCC cell lines. Some of the SCC were lymph node metastases (three) or tumours which had recurred following radiotherapy (seven). We conclude that Harvey ras mutations are not a common event in the pathogenesis or recurrence of SCCs from Caucasian subjects, in contrast to the situation with Indian populations (Saranath et al., 1991).
我们采用聚合酶链反应(PCR)随后直接测序的方法,检测了上消化道人鳞状细胞癌(SCC)中哈维ras基因突变的发生率。在六个乳头状瘤、五个红斑增生病、56个鳞状细胞癌和16个SCC细胞系中,该基因的第12、13、59或61密码子均未检测到突变。部分鳞状细胞癌为淋巴结转移癌(3例)或放疗后复发的肿瘤(7例)。我们得出结论,与印度人群的情况(Saranath等人,1991年)相反,哈维ras基因突变在白种人SCC的发病机制或复发中并非常见事件。